Health Condition 1: G122- Motor neuron disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (a) Diagnosed cases of Amyotrophic Lateral Sclerosis, having less than five years onset. (b) Patients will be selected from the age group of 20-60 years, irrespective of sex, religion and occupation etc. (c) Patients of ALS who are willing to participate in an interventional study. (d) Patients willing to sign the informed consent form
Exclusion criteria
Exclusion criteria: (a) Patients with brain lesions. (b) Patients with systemic or endocrine disorders. (c) Patients with severe respiratory distress. (d) Age less than 20 years and more than 60 years. (e) Patients having other neurological degenerated diseases. (f) Patients not willing to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes will be assessed on the basis of the ALS Functional Rating Scale- Revised (ALSFRS-R) and Norris scale.Timepoint: Day 0 (Baseline), Day 30, and Day 75 (Follow-up) | — |
Secondary
| Measure | Time frame |
|---|---|
| Relief in other symptoms of Amyotrophic Lateral Sclerosis.Timepoint: 75days | — |
Countries
India
Contacts
National Institute of Ayurveda, (DU), Jaipur.